ALLOSTERIC INTERACTIONS IN ASPARTATE TRANSCARBAMYLASE .I. BINDING OF SPECIFIC LIGANDS TO NATIVE ENZYME AND ITS ISOLATED SUBUNITS
ALLOSTERIC INTERACTIONS IN ASPARTATE TRANSCARBAMYLASE .I. BINDING OF SPECIFIC LIGANDS TO NATIVE ENZYME AND ITS ISOLATED SUBUNITS
复制标题
DOI:
10.1021/bi00842a007
复制
发表时间:
1968-01-01
期刊:
影响因子:
2.9
通讯作者:
SCHACHMAN, HK
中科院分区:
文献类型:
--
作者:
CHANGEUX, JP;GERHART, JC;SCHACHMAN, HK
The regulatory enzyme aspartate transcarbamylase (ATCase) from Escherichia coli which is composed of 2 catalytic and 4 regulatory subunits was examined with regard to its stereospecific interactions with ligands. Equilibrium dialysis experiments reveal 4 specific binding sites for succinate (an analog of the substrate, aspartate) and 4 specific sites for the feedback inhibitor, cytidine triphosphate (CTP) or its analog, 5-bromocytidine triphosphate (BrCTP)/molecule of enzyme. On the basis of these results and evidence from dissociation studies, ATCase is viewed as an isologous tetramer, the protomers of which each contain 1 regulatory subunit (mol. wt. 2.7 x 104) and 1/2 of a catalytic subunit (mol. wt. 5.0 x 104). The isolated regulatory subunit possesses 1 binding site for CTP and the isolated catalytic subunit (mol. wt. 1 x 105) possesses 2 sites for succinate. Whereas the binding of ligands to the isolated subunits is normal, unusual effects are observed for the binding of these same ligands to the native enzyme. The ATCase exhibits cooperative effects for succinate binding as revealed by a sigmoidal saturation curve (with a Hill coefficient of 1.6) and antagonistic effects as revealed by a partial reduction of CTP binding by succinate. The binding of succinate and CTP occurs at topographically distinct sites derived exclusively from the folded polypeptide chains of the different subunits, and the cooperative and antagonistic effects are therefore indirect, allosteric effects which must be mediated by the protein itself. In contrast to these indirect effects, ATCase also exhibits a direct effect in which the inhibitor (CTP) and the activator adenosine triphosphate (ATP), appear to compete for a single site on the regulatory subunit.